Streptozocin (CED0003055)

Record Information
Version1.0
Creation Date2009-07-21 20:26:53 UTC
Update Date2026-08-24 16:01:02 UTC
SynCED IDCED0003055
Secondary Accession Numbers
  • CHEM002193
  • T3D2788
Identification
Common NameStreptozocin
ClassSmall Molecule
Description
Streptozocin is a solid compound with the formula C8H15N3O7 and an average molecular weight of 265.22 g/mol. It is exogenous in origin. Streptozocin belongs to the carbohydrates and carbohydrate conjugates, a subclass of organooxygen compounds within the organic compounds. This compound serves as an antineoplastic agent, an antibiotic, a metabolite, and a toxin (PMC7215452 ). Biologically and chemically, it functions as a DNA synthesis inhibitor (PMC7215452 ). It is recorded as being found in healthcare, pharmaceuticals and veterinary products as an antineoplastic agent, as well as in electrical and electronic equipment such as antennas, magnets, and radio transmission systems. The recorded exposure route for this substance is intravenous. Streptozocin has three recorded protein targets: O-GlcNAcase BT_4395, Protein O-GlcNAcase (OGA), and it acts as an antagonist of Solute carrier family 2, facilitated glucose transporter member 2 (SLC2A2). In terms of health effects, the compound is associated with hyperglycemia (PMC5674211 ) and diabetes mellitus (PMC11916920 ).
Contaminant Type
  • Amine
  • Antibiotic
  • Antibiotic, Antineoplastic
  • Antineoplastic Agent
  • Drug
  • Metabolite
  • Organic Compound
  • Synthetic Compound
Chemical Structure
Synonyms
ValueSource
2-Deoxy-2-(((methylnitrosoamino)carbonyl)amino)-D-glucopyranoseChEBI
2-Deoxy-2-(3-methyl-3-nitrosoureido)-D-glucopyranoseChEBI
EstreptozocinaChEBI
N-D-Glucosyl-(2)-n'-nitrosomethylharnstoffChEBI
N-D-Glucosyl-(2)-n'-nitrosomethylureaChEBI
StreptozocineChEBI
StreptozociniumChEBI
StreptozocinumChEBI
StreptozotocinChEBI
ZanosarChEBI
StreptozotocineHMDB
Teva brand OF streptozocinHMDB
Streptozocin teva brandHMDB
2-Deoxy-2-((methylnitrosoamino)carbonyl)amino-D-glucoseHMDB
Chemical FormulaC8H15N3O7
Average Molecular Mass265.221 g/mol
Monoisotopic Mass265.091 g/mol
CAS Registry Number18883-66-4
IUPAC Name3-methyl-3-nitroso-1-[(2S,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]urea
Traditional Namestreptozocin
SMILESCN(N=O)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O
InChI IdentifierInChI=1S/C8H15N3O7/c1-11(10-17)8(16)9-4-6(14)5(13)3(2-12)18-7(4)15/h3-7,12-15H,2H2,1H3,(H,9,16)/t3-,4-,5-,6-,7+/m1/s1
InChI KeyZSJLQEPLLKMAKR-GKHCUFPYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as hexoses. These are monosaccharides in which the sugar unit is a is a six-carbon containing moeity.
KingdomOrganic compounds
Super ClassOrganic oxygen compounds
ClassOrganooxygen compounds
Sub ClassCarbohydrates and carbohydrate conjugates
Direct ParentHexoses
Alternative Parents
Substituents
  • Hexose monosaccharide
  • N-methylnitrosourea
  • Nitrosourea
  • Oxane
  • Nitrosamide
  • Semicarbazide
  • Organic n-nitroso compound
  • Hemiacetal
  • Carbonic acid derivative
  • Secondary alcohol
  • Organic nitroso compound
  • Oxacycle
  • Polyol
  • Organoheterocyclic compound
  • Organonitrogen compound
  • Hydrocarbon derivative
  • Organic oxide
  • Organopnictogen compound
  • Organic nitrogen compound
  • Carbonyl group
  • Primary alcohol
  • Alcohol
  • Aliphatic heteromonocyclic compound
Molecular FrameworkAliphatic heteromonocyclic compounds
External Descriptors
Biological Properties
StatusDetected and Not Quantified
OriginExogenous
Cellular Locations
  • Cytoplasm
  • Extracellular
  • Membrane
Biofluid LocationsNot Available
Tissue LocationsNot Available
Applications
Biological Roles
Chemical Roles
Organoleptic EffectsNot Available
Physical Properties
StateSolid
AppearanceWhite powder.
Experimental Properties
PropertyValue
Melting Point115°C
Boiling PointNot Available
Solubility5070 mg/L
Predicted Properties
PropertyValueSource
Water Solubility33.5 g/LALOGPS
logP-1.7ALOGPS
logP-2.7ChemAxon
logS-0.9ALOGPS
pKa (Strongest Acidic)11.43ChemAxon
pKa (Strongest Basic)-3ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count7ChemAxon
Hydrogen Donor Count5ChemAxon
Polar Surface Area151.92 ŲChemAxon
Rotatable Bond Count3ChemAxon
Refractivity55.96 m³·mol⁻¹ChemAxon
Polarizability23.74 ųChemAxon
Number of Rings1ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyDeposition DateView
Predicted GC-MSPredicted GC-MS Spectrumsplash10-02mj-5940000000-8fb8f1885498bea8bc01Not AvailableView Spectrum
Predicted GC-MSPredicted GC-MS Spectrumsplash10-000i-5384590000-954f20357dc689aab130Not AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-066s-1390000000-8a52d6755935e91be345Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-03di-9730000000-8e7df34a65b316df695eNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-03di-9800000000-8768229ecc0345cd843aNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-000i-9340000000-9e14b4f8a6d8f44c6ad6Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0a4i-9220000000-2ac584cea0c0d26bc11fNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0a4i-9200000000-dd74fa78262e5a7d35e0Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0006-4940000000-29bcfe413e3e5b2dd305Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0536-9100000000-2a734221e4d6f4a10693Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0a4i-9000000000-722b10d68ba035f6a8c2Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-000t-1090000000-4646c5accac0f8935a29Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-01ox-9000000000-d7d9d98474284352116cNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-03di-9300000000-9cad9495adf263c410f9Not AvailableView Spectrum
1D NMR1H NMR Spectrum (1D, D2O, predicted)Not AvailableNot AvailableView Spectrum
1D NMR13C NMR Spectrum (1D, D2O, predicted)Not AvailableNot AvailableView Spectrum
Toxicity Profile
Toxicity Values
Toxicity ValueOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalToxicity RatingReference
2031.0 Log mg/kg [1100:3600]RatLD50oralpredictedNot AvailableNot Available
40.0 mg/kg-day MouseLOELinjectionexperimentalNot AvailableECOTOX - EPA ORD
100.0 mg/kg-day MouseLOELinjectionexperimentalNot AvailableECOTOX - EPA ORD
40.0 mg/kg-day MouseLOELinjectionexperimentalNot AvailableECOTOX - EPA ORD
Toxicity / Toxin ClassNot Available
Mechanism of ToxicityStreptozotocin is a naturally occurring chemical that is particularly toxic to the insulin-producing beta cells of the pancreas. It is used in medical research to produce an animal model for Type 1 diabetes in large dose as well as Type 2 diabetes with multiple low doses. Streptozotocin is similar enough to glucose to be transported into the cell by the glucose transport protein GLUT2, but is not recognized by the other glucose transporters. This explains its relative toxicity to beta cells, since these cells have relatively high levels of GLUT2. Streptozotocin is a glucosamine-nitrosourea (i.e. alkylating) compound. As with other alkylating agents in the nitrosourea class, it is toxic to cells by causing damage to the DNA, though other mechanisms may also contribute.
Carcinogenicity (IARC Classification)2B, possibly carcinogenic to humans. (6)
Minimum Risk LevelNot Available
SymptomsSymptoms of overdose include nausea and vomiting, anorexia, myelosuppression; and nephrotoxicity.
TreatmentNot Available
Health Effects
Health EffectRelationshipDirectionDescriptionReference
gestational diabetesAssociated With?Not AvailableA disorder, occurring in pregnant women, characterized by hyperglycemia.PMC4623071
diabetes mellitusAssociated With?Not AvailableA glucose metabolism disease characterized by chronic hyperglycaemia with disturbances of carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin action, or both. (DO)PMC11916920 , PMC10058777
neuropathic painAssociated With?Not AvailableNot AvailablePMC13334684
hyperglycemiaAssociated With?Not AvailableA disorder characterized by laboratory test results that indicate an elevation in the concentration of blood sugar. It is usually an indication of diabetes mellitus or glucose intolerance. (NCI CTCAE)PMC5674211 , PMC13393497
type 1 diabetes mellitusNot AvailableNot AvailableNot AvailablePMC11687964
type 1 diabetes mellitusAssociated With?Not AvailableNot AvailablePMC8880550
Oxidative StressAssociated With?increaseNot AvailablePMC4090508 , PMC10761490
Weight lossAssociated With?Not AvailableNot AvailablePMC13393497
infectious diseaseNot AvailableNot AvailableNot AvailablePMC10886320
KetosisAssociated With?Not AvailableNot AvailablePMC13128434
GlycosuriaAssociated With?Not AvailableNot AvailablePMC4431732
Pancreatitis, Acute NecrotizingAssociated With?Not AvailableNot AvailablePMC13393497
KetonuriaAssociated With?Not AvailableNot AvailablePMC4431732
Exposure Sources
Source IDSourceSectorReference
CEDs000051Surface water?Surface water can serve as a significant vector for the introduction of synthetic chemical contaminants into aquatic ecosystems.Aquatic systems & sedimentsPMC10886320
CEDs000358Antineoplastic agents?Antineoplastic agents are a class of synthetic chemicals used primarily in the treatment of cancer.Healthcare, pharmaceuticals & veterinary productsNot Available
CEDs000483WWTP effluent?Wastewater treatment plant (WWTP) effluent can serve as a significant source of synthetic chemical contamination in the environment.Wastewater, sanitation & biosolidsPMC10886320
CEDs000506Antennas?Antennas, commonly used in communication technologies, can be a source of synthetic chemical contamination through the materials and coatings used in their construction.Electrical & Electronic EquipmentPubChem
CEDs000511Conductors Or Conductive Bodies Characterised By The Conductive Materials?Conductors, or conductive bodies, are materials that allow the flow of electrical current, typically made from metals such as copper, aluminum, or silver.Electrical & Electronic EquipmentPubChem
CEDs000519Electrodes?Electrodes, used in various electrical and electronic applications, can be a source of synthetic chemical contamination due to the materials from which they are constructed and the processes involved in their manufacturing.Electrical & Electronic EquipmentPubChem
CEDs000527Magnets?Magnets, commonly used in various electrical and electronic applications, can be a source of synthetic chemical contamination due to the materials used in their production.Electrical & Electronic EquipmentPubChem
CEDs000530Radio Transmission Systems?Radio transmission systems utilize a variety of synthetic chemicals in their manufacturing and maintenance processes.Electrical & Electronic EquipmentPubChem
CEDs000545Food Preservation?Food preservation often involves the use of synthetic chemicals, such as preservatives, flavor enhancers, and color additives, to extend shelf life and enhance the sensory qualities of food products.Food, food processing & cookwarePubChem
CEDs000561Perfumes Within Detergents And Soaps?Perfumes within detergents and soaps are synthetic fragrance compounds added to enhance the sensory experience of cleaning products.Household cleaning & consumer productsPubChem
CEDs000610Aftersun Products?Aftersun products are designed to soothe and hydrate the skin after sun exposure, often containing various synthetic chemicals such as emollients, preservatives, and fragrances.Personal care & cosmeticsPubChem
CEDs000611Anti Perspirants Or Body Deoderants?Antiperspirants and body deodorants commonly contain synthetic chemicals such as aluminum compounds, parabens, and synthetic fragrances.Personal care & cosmeticsPubChem
CEDs000615Eye Makeup Products?Eye makeup products, including mascaras, eyeliners, and eyeshadows, often contain a variety of synthetic chemicals such as pigments, preservatives, and film-forming agents.Personal care & cosmeticsPubChem
CEDs000618Lip Makeup Products?Lip makeup products, such as lipsticks, lip glosses, and lip liners, often contain a variety of synthetic chemicals, including pigments, preservatives, and emollients.Personal care & cosmeticsPubChem
CEDs000630Toys?Toys, particularly those made from synthetic materials such as plastics, can be a source of chemical contamination due to the presence of various additives and compounds used in their production.Recreation & sports surfacesPubChem
CEDs000632Apparel?Apparel production often involves the use of various synthetic chemicals, including dyes, finishing agents, and preservatives.Textiles, leather & furnishingsPubChem
CEDs000650Purses Luggage Hand Bags?Purses, luggage, and handbags are often manufactured using synthetic materials such as polyvinyl chloride (PVC), polyurethane, and various types of nylon.Textiles, leather & furnishingsPubChem
CEDs000667Gaseous Fire Fighting?Gaseous fire fighting systems utilize synthetic chemicals, such as halocarbons and inert gases, to suppress fires through chemical and physical processes.Fire suppression systems & agentsPubChem
CEDs000685Ceramics?Ceramics can be a source of synthetic chemical contamination through various additives and processing agents used in their production.Building & ConstructionPubChem
CEDs000692Silica Free Oxide Glass?Silica Free Oxide Glass is a type of glass that is produced using alternative materials to traditional silica-based formulations.Building & ConstructionPubChem
CEDs000696Nanotechnology?Nanotechnology involves the manipulation of materials at the molecular or atomic level, typically within the range of 1 to 100 nanometers.Industrial manufacturing & chemical processingPubChem
CEDs000698Jewellery?Jewellery production often involves the use of various synthetic chemicals during the extraction and processing of metals.Mining & metal processingPubChem
CEDs000732Spectacle Cases?Spectacle cases can serve as a source of synthetic chemical contamination due to the materials used in their production, such as polycarbonate, PVC, and various plastics, which may leach harmful substances over time.Healthcare, pharmaceuticals & veterinary productsPubChem
CEDs000744Water, Wastewater, & Sewage Treatment?Water, wastewater, and sewage treatment processes are critical for managing and mitigating pollutants in water systems.Wastewater, sanitation & biosolidsPubChem
CEDs02090WasteWaste management, landfill & incinerationPMC10886320
CEDs02265River WaterAquatic systems & sedimentsPMC10886320
CEDs02456Msunduzi RiverAquatic systems & sedimentsPMC10886320
CEDs03012Wastewater EffluentsWastewater, sanitation & biosolidsPMC10886320
CEDs03028Wastewater EffluentWastewater, sanitation & biosolidsPMC10886320
Pathways
2 pathwaysPathway Source: PathBank
Targets
StructureProteinUniProt IDOrganismRelationshipDetails
CD44 antigen structureClick to view 3D structureCD44 antigenP16070HumansPredicted (SEA)
Prediction Confidence Score
0.344
Applicability Domain
0.344
Statistical Significance
8.00e-05
Supporting Reference Compounds
1
E-value
0.622794
CD44 antigen structureClick to view 3D structureCD44 antigenP15379Mus musculusPredicted (SEA)
Prediction Confidence Score
0.344
Applicability Domain
0.344
Statistical Significance
8.00e-05
Supporting Reference Compounds
1
E-value
0.622794
N-acetylglucosamine-6-phosphate deacetylase structureClick to view 3D structureN-acetylglucosamine-6-phosphate deacetylaseQ9Y303HumansPredicted (SEA)
Prediction Confidence Score
0.327
Applicability Domain
0.327
Statistical Significance
7.00e-05
Supporting Reference Compounds
1
E-value
0.544945
Lectin structureClick to view 3D structureLectinB4EH87Burkholderia cenocepacia (strain ATCC BAA-245 / DSM 16553 / LMG 16656/ NCTC 13227 / J2315 / CF5610) (Burkholderia cepacia (strain J2315))Predicted (SEA)
Prediction Confidence Score
0.318
Applicability Domain
0.405
Statistical Significance
2.90e-04
Supporting Reference Compounds
3
E-value
2.25763
Click to view 3D structureKiller cell lectin-like receptor subfamily B member 1AP27471Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.297
Applicability Domain
0.328
Statistical Significance
6.00e-05
Supporting Reference Compounds
2
E-value
0.467095
Type 1 fimbrin D-mannose specific adhesin structureClick to view 3D structureType 1 fimbrin D-mannose specific adhesinP08191Escherichia coli K-12Predicted (SEA)
Prediction Confidence Score
0.297
Applicability Domain
0.405
Statistical Significance
5.10e-04
Supporting Reference Compounds
4
E-value
3.97031
Oligo-1,6-glucosidase IMA1 structureClick to view 3D structureOligo-1,6-glucosidase IMA1P53051Saccharomyces cerevisiae S288cPredicted (SEA)
Prediction Confidence Score
0.276
Applicability Domain
0.276 Low confidence
Statistical Significance
0.0011
Supporting Reference Compounds
1
E-value
8.64126
Click to view 3D structureN-acetyllactosaminide alpha-1,3-galactosyltransferaseP50127Sus scrofaPredicted (SEA)
Prediction Confidence Score
0.268
Applicability Domain
0.268 Low confidence
Statistical Significance
6.70e-04
Supporting Reference Compounds
1
E-value
5.2159
Galectin-7 structureClick to view 3D structureGalectin-7P47929HumansPredicted (SEA)
Prediction Confidence Score
0.257
Applicability Domain
0.281 Low confidence
Statistical Significance
4.50e-04
Supporting Reference Compounds
4
E-value
3.50322
Galectin-3 structureClick to view 3D structureGalectin-3P17931HumansPredicted (SEA)
Prediction Confidence Score
0.251
Applicability Domain
0.281 Low confidence
Statistical Significance
0.002
Supporting Reference Compounds
23
E-value
15.4141
Peptidoglycan-N-acetylglucosamine deacetylase structureClick to view 3D structurePeptidoglycan-N-acetylglucosamine deacetylaseQ8DP63Streptococcus pneumoniae (strain ATCC BAA-255 / R6)Predicted (SEA)
Prediction Confidence Score
0.25
Applicability Domain
0.25 Low confidence
Statistical Significance
9.30e-04
Supporting Reference Compounds
1
E-value
7.23998
Click to view 3D structureAlpha-amylaseQ7M328Sus scrofa domesticusPredicted (SEA)
Prediction Confidence Score
0.25
Applicability Domain
0.25 Low confidence
Statistical Significance
2.30e-04
Supporting Reference Compounds
1
E-value
1.79053
Galectin-9 structureClick to view 3D structureGalectin-9O00182HumansPredicted (SEA)
Prediction Confidence Score
0.247
Applicability Domain
0.281 Low confidence
Statistical Significance
0.0017
Supporting Reference Compounds
15
E-value
13.5458
Cytidine deaminase structureClick to view 3D structureCytidine deaminaseP32320HumansPredicted (SEA)
Prediction Confidence Score
0.245
Applicability Domain
0.255 Low confidence
Statistical Significance
0.0021
Supporting Reference Compounds
4
E-value
16.4262
Beta-1,4-galactosyltransferase 1 structureClick to view 3D structureBeta-1,4-galactosyltransferase 1P08037Bos taurusPredicted (SEA)
Prediction Confidence Score
0.244
Applicability Domain
0.333
Statistical Significance
0.0014
Supporting Reference Compounds
2
E-value
10.7432
1D-myo-inositol 2-acetamido-2-deoxy-alpha-D-glucopyranoside deacetylase structureClick to view 3D structure1D-myo-inositol 2-acetamido-2-deoxy-alpha-D-glucopyranoside deacetylaseP9WJN3Mycobacterium tuberculosisPredicted (SEA)
Prediction Confidence Score
0.241
Applicability Domain
0.241 Low confidence
Statistical Significance
8.30e-04
Supporting Reference Compounds
1
E-value
6.46149
Adenosine receptor A1 structureClick to view 3D structureAdenosine receptor A1P30542HumansPredicted (SEA)
Prediction Confidence Score
0.239
Applicability Domain
0.286 Low confidence
Statistical Significance
0.1334
Supporting Reference Compounds
302
E-value
1038.2
Cytidine deaminase structureClick to view 3D structureCytidine deaminaseP56389Mus musculusPredicted (SEA)
Prediction Confidence Score
0.238
Applicability Domain
0.264 Low confidence
Statistical Significance
0.0028
Supporting Reference Compounds
5
E-value
22.0313
Carbonic anhydrase 12 structureClick to view 3D structureCarbonic anhydrase 12O43570HumansPredicted (SEA)
Prediction Confidence Score
0.236
Applicability Domain
0.263 Low confidence
Statistical Significance
0.1824
Supporting Reference Compounds
332
E-value
1419.89
Solute carrier family 28 member 3 structureClick to view 3D structureSolute carrier family 28 member 3Q9HAS3HumansPredicted (SEA)
Prediction Confidence Score
0.235
Applicability Domain
0.25 Low confidence
Statistical Significance
0.0041
Supporting Reference Compounds
3
E-value
32.0739
Click to view 3D structureGalectin-7O54974Mus musculusPredicted (SEA)
Prediction Confidence Score
0.23
Applicability Domain
0.274 Low confidence
Statistical Significance
0.0013
Supporting Reference Compounds
2
E-value
10.5096
Carbonic anhydrase 7 structureClick to view 3D structureCarbonic anhydrase 7P43166HumansPredicted (SEA)
Prediction Confidence Score
0.229
Applicability Domain
0.263 Low confidence
Statistical Significance
0.1735
Supporting Reference Compounds
242
E-value
1351.0
Carbonic anhydrase 1 structureClick to view 3D structureCarbonic anhydrase 1P00915HumansPredicted (SEA)
Prediction Confidence Score
0.229
Applicability Domain
0.263 Low confidence
Statistical Significance
0.2551
Supporting Reference Compounds
407
E-value
1985.93
Asialoglycoprotein receptor 1 structureClick to view 3D structureAsialoglycoprotein receptor 1P07306HumansPredicted (SEA)
Prediction Confidence Score
0.228
Applicability Domain
0.228 Low confidence
Statistical Significance
2.30e-04
Supporting Reference Compounds
1
E-value
1.79053
Beta-hexosaminidase structureClick to view 3D structureBeta-hexosaminidaseQ9HZK0Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG12228)Predicted (SEA)
Prediction Confidence Score
0.226
Applicability Domain
0.226 Low confidence
Statistical Significance
3.40e-04
Supporting Reference Compounds
1
E-value
2.64687
Click to view 3D structureSolute carrier family 2, facilitated glucose transporter member 2P11168HumansKnownNot Available
Protein O-GlcNAcase structureClick to view 3D structureProtein O-GlcNAcaseO60502HumansKnownNot Available
Concentrations
Not Available
External Links
DrugBank IDDB00428
HMDB IDHMDB0014572
FooDB IDNot Available
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDNot Available
METLIN IDNot Available
PDB IDNot Available
Wikipedia LinkStreptozocin
Chemspider ID27273
ChEBI ID9288
PubChem Compound ID29327
Kegg Compound IDC07313
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis ReferenceNot Available
MSDSLink
General References
  1. Brentjens R, Saltz L: Islet cell tumors of the pancreas: the medical oncologist's perspective. Surg Clin North Am. 2001 Jun;81(3):527-42. [PubMed: 11459269]
  2. Wang Z, Gleichmann H: GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice. Diabetes. 1998 Jan;47(1):50-6. [PubMed: 9421374]
  3. Schnedl WJ, Ferber S, Johnson JH, Newgard CB: STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells. Diabetes. 1994 Nov;43(11):1326-33. [PubMed: 7926307]
  4. VAVRA JJ, DEBOER C, DIETZ A, HANKA LJ, SOKOLSKI WT: Streptozotocin, a new antibacterial antibiotic. Antibiot Annu. 1959-1960;7:230-5. [PubMed: 13841501]
  5. Mansford KR, Opie L: Comparison of metabolic abnormalities in diabetes mellitus induced by streptozotocin or by alloxan. Lancet. 1968 Mar 30;1(7544):670-1. [PubMed: 4170654]
  6. International Agency for Research on Cancer (2014). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. - http://monographs.iarc.fr/index.php
  7. Drugs.com - http://www.drugs.com/cons/Streptozocin.html
  8. BC Breast Cancer Agency (2007). Streptozocin. - http://www.bccancer.bc.ca/HPI/DrugDatabase/DrugIndexPro/Streptozocin.htm